TAYLOR ALI: Open Payments
NPI 1699336230 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 36 payments from 11 companies in 2025. Trend: 2023 $1,158 · 2024 $685 · 2025 $734
Food & beverage: $644Education: $90
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 13 | $177 |
| MILLICENT US INC | 7 | $136 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $116 |
| Sumitomo Pharma America, Inc. | 3 | $75 |
| Astellas Pharma US Inc | 3 | $64 |
| Biogen, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $42 |
| Organon LLC | 1 | $21 |
| Exeltis, USA Inc. | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
Products named: Lynkuet, MYFEMBREE, Veozah, ZURZUVAE, COMIRNATY, INTRAROSA, NEXPLANON, SLYND.
Industry payments across NY — which companies pay providers there.
